跳至主要内容
临床试验/CTRI/2021/06/034357
CTRI/2021/06/034357尚未招募未知

Anaesthetic implications of post-COVID mucormycosis in a tertiary care hospital, West Bengal, India - Mucor, Anaesthesia

Dr Swati Datta0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1. Patients with RTPCR confirmed recent (with in last one & a half months) infection with SARS-COV-2 and current RTPCR negative status
  • 2. Presence of more than 1 of following clinical features:
  • i) Frontal headache
  • ii) Blurring of vision
  • iii) Numbness of chick
  • iv) Facial swelling
  • v) Features suggestive of cranial nerve involvement
  • vi) Nasal or sinus congestion
  • vii) Black lesion on nasal bridge or upper inside of mouth (palatal region)
  • 3. Undergoing surgical resection of rhino-orbito-cerebral mucormycoses

排除标准

  • 1. COVID-19 RTPCR positive mucormycosis
  • 2. Patients with incomplete medical records
  • 3. Post COVID mucormycosis patients who are critically ill, not undergoing surgical treatment

研究者

发起方
Dr Swati Datta

相似试验

Mucormycosis and Anaesthesia | 临床试验